Abstract
The use of blood and blood components has contributed hugely to advances made in medicine and surgery but, as has been discovered, their use is certainly not without risk. Contaminated blood and components can transmit disease and, as our knowledge increases, more risks can be identified.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
WHO Expert Committee on Biological Standardisation, WHO Technical Report Series 840, 1994.
Guide to the Preparation, Use and Quality Assurance of Blood Components, Council of Europe Publishing, Strasbourg, France. 6th Edition, 2000.
Commission of the European Communities. The Rules Governing Medicinal Products in the European Community Vol IV Good Manufacturing Practice for Medicinal Products, Luxembourg: Office for Official Publications of the EC, 1992.
Guidelines for the Blood Transfusion Services in the United Kingdom, The Stationery Office, London: 4th Edition, 2000.
PIC/S GMP Guide for Blood Centres (Draft).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Kavanagh, M.L. (2001). Legal and Regulatory Aspects of Blood Transfusion. In: Sibinga, C.T.S., Cash, J.D. (eds) Transfusion Medicine: Quo Vadis? What Has Been Achieved, What Is to Be Expected. Developments in Hematology and Immunology, vol 36. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1735-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1735-1_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5700-1
Online ISBN: 978-1-4615-1735-1
eBook Packages: Springer Book Archive